ID   3S11_NAJHA              Reviewed;          61 AA.
AC   P68417; P01429;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   25-MAY-2022, entry version 60.
DE   RecName: Full=Short neurotoxin 1;
DE   AltName: Full=Neurotoxin alpha;
OS   Naja annulifera (Banded Egyptian cobra) (Naja haje annulifera).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Elapidae; Elapinae; Naja.
OX   NCBI_TaxID=96794;
RN   [1]
RP   PROTEIN SEQUENCE, TOXIC DOSE, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=4308169; DOI=10.1016/s0021-9258(17)36396-2;
RA   Botes D.P., Strydom D.J.;
RT   "A neurotoxin, toxin alpha, from Egyptian cobra (Naja haje haje) venom. I.
RT   Purification, properties, and complete amino acid sequence.";
RL   J. Biol. Chem. 244:4147-4157(1969).
CC   -!- FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and
CC       inhibit acetylcholine from binding to the receptor, thereby impairing
CC       neuromuscular transmission.
CC   -!- FUNCTION: Produces peripheral paralysis by blocking neuromuscular
CC       transmission at the postsynaptic site. Binds to the muscular nicotinic
CC       acetylcholine receptor.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:4308169}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland. {ECO:0000305}.
CC   -!- TOXIC DOSE: LD(50) is 0.105 mg/kg by subcutaneous injection.
CC       {ECO:0000269|PubMed:4308169}.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Short-chain
CC       subfamily. Type I alpha-neurotoxin sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PIR; A92049; N1NJ1E.
DR   AlphaFoldDB; P68417; -.
DR   SMR; P68417; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030550; F:acetylcholine receptor inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0099106; F:ion channel regulator activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   CDD; cd00206; snake_toxin; 1.
DR   Gene3D; 2.10.60.10; -; 1.
DR   InterPro; IPR003571; Snake_3FTx.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR018354; Snake_toxin_con_site.
DR   SUPFAM; SSF57302; SSF57302; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Acetylcholine receptor inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Ion channel impairing toxin; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Toxin.
FT   CHAIN           1..61
FT                   /note="Short neurotoxin 1"
FT                   /evidence="ECO:0000269|PubMed:4308169"
FT                   /id="PRO_0000093596"
FT   DISULFID        3..23
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Z0"
FT   DISULFID        17..40
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Z0"
FT   DISULFID        42..53
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Z0"
FT   DISULFID        54..59
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Z0"
SQ   SEQUENCE   61 AA;  6844 MW;  7504536BBE96DE76 CRC64;
     LECHNQQSSQ PPTTKTCPGE TNCYKKRWRD HRGSITERGC GCPSVKKGIE INCCTTDKCN
     N